Home

donatore Assedio oblungo mrx34 clinical trial Embody Leopardo rappresentazione

MiRNA-Based Therapeutics in Oncology, Realities, and Challenges | IntechOpen
MiRNA-Based Therapeutics in Oncology, Realities, and Challenges | IntechOpen

miRNA therapeutics: a new class of drugs with potential therapeutic  applications in the heart | Future Medicinal Chemistry
miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart | Future Medicinal Chemistry

The "Macro" World of microRNAs in Hepatocellular Carcinoma. - Abstract -  Europe PMC
The "Macro" World of microRNAs in Hepatocellular Carcinoma. - Abstract - Europe PMC

MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic  modulators | SpringerLink
MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators | SpringerLink

miRNA therapeutics: a new class of drugs with potential therapeutic  applications in the heart | Future Medicinal Chemistry
miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart | Future Medicinal Chemistry

RNA-targeted therapeutics in cancer clinical trials: Current status and  future directions - Cancer Treatment Reviews
RNA-targeted therapeutics in cancer clinical trials: Current status and future directions - Cancer Treatment Reviews

MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate  in cancer | Journal of Experimental & Clinical Cancer Research | Full Text
MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer | Journal of Experimental & Clinical Cancer Research | Full Text

MicroRNA therapeutics: towards a new era for the management of cancer and  other diseases | Nature Reviews Drug Discovery
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases | Nature Reviews Drug Discovery

MiRNA-Based Therapeutics in Oncology, Realities, and Challenges | IntechOpen
MiRNA-Based Therapeutics in Oncology, Realities, and Challenges | IntechOpen

mirn_Current_Folio_10K
mirn_Current_Folio_10K

PDF) Phase I study of MRX34, a liposomal miR-34a mimic, administered twice  weekly in patients with advanced solid tumors
PDF) Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors

How to Train Your Dragon: Targeted Delivery of MicroRNA to Cancer Cells In  Vivo: Molecular Therapy
How to Train Your Dragon: Targeted Delivery of MicroRNA to Cancer Cells In Vivo: Molecular Therapy

Frontiers | MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell  Inhibitor, and Potential Anticancer Therapeutic | Cell and Developmental  Biology
Frontiers | MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic | Cell and Developmental Biology

Therapeutic advances of miRNAs: A preclinical and clinical update -  ScienceDirect
Therapeutic advances of miRNAs: A preclinical and clinical update - ScienceDirect

SEC Filing - Synlogic
SEC Filing - Synlogic

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with  advanced solid tumours | British Journal of Cancer
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours | British Journal of Cancer

Role of miR‑34 in gastric cancer: From bench to bedside (Review)
Role of miR‑34 in gastric cancer: From bench to bedside (Review)

The Risks of miRNA Therapeutics: In a Drug Target Perspective | DDDT
The Risks of miRNA Therapeutics: In a Drug Target Perspective | DDDT

microRNA Therapeutics in Cancer — An Emerging Concept - eBioMedicine
microRNA Therapeutics in Cancer — An Emerging Concept - eBioMedicine

Analyses of discontinuation of two miRNA-based clinical projects. (A... |  Download Scientific Diagram
Analyses of discontinuation of two miRNA-based clinical projects. (A... | Download Scientific Diagram

MicroRNAs in liver cancer: a model for investigating pathogenesis and novel  therapeutic approaches. - Abstract - Europe PMC
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches. - Abstract - Europe PMC

Clinical applications of microRNAs | F1000Research
Clinical applications of microRNAs | F1000Research